Matthias Götte

9.5k total citations · 5 hit papers
138 papers, 6.1k citations indexed

About

Matthias Götte is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Matthias Götte has authored 138 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Infectious Diseases, 71 papers in Virology and 58 papers in Molecular Biology. Recurrent topics in Matthias Götte's work include HIV/AIDS drug development and treatment (83 papers), HIV Research and Treatment (71 papers) and DNA and Nucleic Acid Chemistry (22 papers). Matthias Götte is often cited by papers focused on HIV/AIDS drug development and treatment (83 papers), HIV Research and Treatment (71 papers) and DNA and Nucleic Acid Chemistry (22 papers). Matthias Götte collaborates with scholars based in Canada, United States and Germany. Matthias Götte's co-authors include Egor P. Tchesnokov, Danielle Porter, Joy Y. Feng, Calvin J. Gordon, Mark A. Wainberg, Jason K. Perry, Emma Woolner, Bruno Marchand, Raymond F. Schinazi and Jordan J. Feld and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Matthias Götte

132 papers receiving 6.0k citations

Hit Papers

Remdesivir is a direct-ac... 2019 2026 2021 2023 2020 2020 2019 2021 2022 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency
    2020 698 citations Calvin J. Gordon, Egor P. Tchesnokov et al. Journal of Biological Chemistry profile →
  2. The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus
    2020 621 citations Calvin J. Gordon, Egor P. Tchesnokov et al. Journal of Biological Chemistry profile →
  3. Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir
    2019 450 citations Egor P. Tchesnokov, Joy Y. Feng et al. Viruses profile →
  4. Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template
    2021 212 citations Calvin J. Gordon, Egor P. Tchesnokov et al. Journal of Biological Chemistry profile →
  5. Mutations in the SARS-CoV-2 RNA-dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms
    2022 139 citations Laura J. Stevens, Andrea J. Pruijssers et al. Science Translational Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthias Götte Canada 40 4.2k 2.1k 1.8k 1.2k 567 138 6.1k
Yuxian He China 50 9.0k 2.1× 2.4k 1.1× 3.0k 1.6× 1.6k 1.4× 354 0.6× 153 11.9k
Joy Y. Feng United States 30 5.2k 1.2× 1.4k 0.7× 732 0.4× 822 0.7× 280 0.5× 67 6.6k
Dirk Jochmans Belgium 32 3.1k 0.7× 930 0.4× 1.1k 0.6× 750 0.6× 185 0.3× 94 4.3k
Graham Simmons United States 49 5.7k 1.4× 1.4k 0.7× 2.3k 1.3× 1.7k 1.5× 149 0.3× 132 10.0k
Subhash G. Vasudevan Singapore 62 5.0k 1.2× 2.4k 1.2× 1.6k 0.9× 995 0.9× 200 0.4× 202 11.4k
George R. Painter United States 36 2.1k 0.5× 1.1k 0.6× 1.0k 0.6× 1.6k 1.4× 285 0.5× 98 3.9k
Yaoxing Huang United States 38 4.2k 1.0× 1.9k 0.9× 4.9k 2.7× 1.3k 1.1× 275 0.5× 84 9.1k
Étienne Decroly France 47 5.3k 1.3× 2.9k 1.4× 1.0k 0.6× 998 0.9× 86 0.2× 126 8.7k
Donald F. Smee United States 55 3.7k 0.9× 2.3k 1.1× 1.2k 0.7× 4.4k 3.8× 343 0.6× 216 9.5k
Jan Münch Germany 45 2.6k 0.6× 2.3k 1.1× 2.8k 1.5× 1.4k 1.2× 116 0.2× 182 7.3k

Countries citing papers authored by Matthias Götte

Since Specialization
Citations

This map shows the geographic impact of Matthias Götte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Götte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Götte more than expected).

Fields of papers citing papers by Matthias Götte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Götte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Götte. The network helps show where Matthias Götte may publish in the future.

Co-authorship network of co-authors of Matthias Götte

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Götte. A scholar is included among the top collaborators of Matthias Götte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Götte. Matthias Götte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Li, Jiani, Ross Martin, Dong Han, et al.. (2024). SARS-CoV-2 resistance analyses from the Phase 3 PINETREE study of remdesivir treatment in nonhospitalized participants. Antimicrobial Agents and Chemotherapy. 69(2). e0123824–e0123824. 2 indexed citations
3.
Götte, Matthias, et al.. (2024). A quantum inspired approach to learning dynamical laws from data—block-sparsity and gauge-mediated weight sharing. Machine Learning Science and Technology. 5(2). 25064–25064.
4.
Malone, Brandon, Jason K. Perry, Paul Dominic B. Olinares, et al.. (2023). Structural basis for substrate selection by the SARS-CoV-2 replicase. Nature. 614(7949). 781–787. 42 indexed citations
5.
Stevens, Laura J., Andrea J. Pruijssers, Calvin J. Gordon, et al.. (2022). Mutations in the SARS-CoV-2 RNA-dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms. Science Translational Medicine. 14(656). eabo0718–eabo0718. 139 indexed citations breakdown →
6.
Gordon, Calvin J., Egor P. Tchesnokov, Raymond F. Schinazi, & Matthias Götte. (2021). Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template. Journal of Biological Chemistry. 297(1). 100770–100770. 212 indexed citations breakdown →
7.
Feng, Jianhua, John A. Bilello, Darius Babusis, et al.. (2021). NRTIs tenofovir, TAF, TDF, and FTC are inactive against SARS-CoV-2. HIV Medicine. 22. 59–59.
8.
Lo, Michael K., César G. Albariño, Jason K. Perry, et al.. (2020). Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases. Proceedings of the National Academy of Sciences. 117(43). 26946–26954. 45 indexed citations
9.
Freedman, Holly, Juthika Kundu, Egor P. Tchesnokov, et al.. (2020). Application of Molecular Dynamics Simulations to the Design of Nucleotide Inhibitors Binding to Norovirus Polymerase. Journal of Chemical Information and Modeling. 60(12). 6566–6578. 5 indexed citations
10.
John, Jubi, Nicholas J. Bennett, Kalyan Das, et al.. (2015). Pronounced Inhibition Shift from HIV Reverse Transcriptase to Herpetic DNA Polymerases by Increasing the Flexibility of α-Carboxy Nucleoside Phosphonates. Journal of Medicinal Chemistry. 58(20). 8110–8127. 7 indexed citations
11.
Götte, Matthias. (2014). Resistance to nucleotide analogue inhibitors of hepatitis C virus NS5B: mechanisms and clinical relevance. Current Opinion in Virology. 8. 104–108. 11 indexed citations
12.
Wyl, Viktor von, Maryam Ehteshami, Jori Symons, et al.. (2010). Epidemiological and Biological Evidence for a Compensatory Effect of Connection Domain Mutation N348I on M184V in HIV‐1 Reverse Transcriptase. The Journal of Infectious Diseases. 201(7). 1054–1062. 23 indexed citations
13.
Ehteshami, Maryam & Matthias Götte. (2009). Effects of mutations in the connection and RNase H domains of HIV-1 reverse transcriptase on drug susceptibility.. PubMed. 10(4). 224–35. 22 indexed citations
14.
Tchesnokov, Egor P., et al.. (2008). Delayed Chain Termination Protects the Anti-hepatitis B Virus Drug Entecavir from Excision by HIV-1 Reverse Transcriptase. Journal of Biological Chemistry. 283(49). 34218–34228. 55 indexed citations
15.
Dash, Chandravanu, et al.. (2008). Examining the ribonuclease H primer grip of HIV-1 reverse transcriptase by charge neutralization of RNA/DNA hybrids. Nucleic Acids Research. 36(20). 6363–6371. 11 indexed citations
16.
Ehteshami, Maryam, Egor P. Tchesnokov, Chandravanu Dash, et al.. (2008). Mutations M184V and Y115F in HIV-1 Reverse Transcriptase Discriminate against “Nucleotide-competing Reverse Transcriptase Inhibitors”. Journal of Biological Chemistry. 283(44). 29904–29911. 38 indexed citations
17.
Castro, Christian, Eric D. Smidansky, Kenneth R. Maksimchuk, et al.. (2007). Two proton transfers in the transition state for nucleotidyl transfer catalyzed by RNA- and DNA-dependent RNA and DNA polymerases. Proceedings of the National Academy of Sciences. 104(11). 4267–4272. 121 indexed citations
18.
Eggink, Dirk, Marleen C.D.G. Huigen, Charles A. Boucher, Matthias Götte, & Monique Nijhuis. (2007). Insertions in the β3–β4 loop of reverse transcriptase of human immunodeficiency virus type 1 and their mechanism of action, influence on drug susceptibility and viral replication capacity. Antiviral Research. 75(2). 93–103. 8 indexed citations
19.
Jochmans, Dirk, Jérôme Deval, Bart Kesteleyn, et al.. (2006). Indolopyridones Inhibit Human Immunodeficiency Virus Reverse Transcriptase with a Novel Mechanism of Action. Journal of Virology. 80(24). 12283–12292. 77 indexed citations
20.
Hermann, Thomas, Thomas Meier, Matthias Götte, & Hermann Heumann. (1994). The ‘helix clamp’ in HIV-1 reverse transcrptase: a new nucleic acide binding motif common in nucleic acid polymerases. Nucleic Acids Research. 22(22). 4625–4633. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuxian He Breakdown of academic impact, for papers by Joy Y. Feng Breakdown of academic impact, for papers by Dirk Jochmans Breakdown of academic impact, for papers by Graham Simmons Breakdown of academic impact, for papers by Subhash G. Vasudevan Breakdown of academic impact, for papers by George R. Painter Breakdown of academic impact, for papers by Yaoxing Huang Breakdown of academic impact, for papers by Étienne Decroly Breakdown of academic impact, for papers by Donald F. Smee Breakdown of academic impact, for papers by Jan Münch
Rankless by CCL
2026